Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

Authors

Dave Singh, University of Manchester
Mona Bafadhel, University of Oxford
Christopher E. Brightling, University of Leicester
Frank C. Sciurba, University of Pittsburgh
Jeffrey L. Curtis, VA Ann Arbor Healthcare System
Fernando J. Martinez, Weill Cornell Medical College
Cara B. Pasquale, COPD Foundation
Debora D. Merrill, COPD Foundation
Norbert Metzdorf, Boehringer Ingelheim International GmbH
Stefano Petruzzelli, Chiesi Farmaceutici
Ruth Tal-Singer, COPD Foundation
Christopher Compton, GlaxoSmithKline
Stephen I. Rennard, University of Nebraska Medical CenterFollow
Ubaldo J. Martin, AstraZeneca

Document Type

Article

Journal Title

American Journal of Respiratory and Critical Care Medicine

Publication Date

2020

Volume

202

MeSH Headings

Clinical Trials as Topic, Eosinophils, Humans, Leukocyte Count, Pulmonary Disease, Chronic Obstructive

DOI Link

10.1164/rccm.201912-2384PP

ISSN

1535-4970

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Singh, Dave; Bafadhel, Mona; Brightling, Christopher E.; Sciurba, Frank C.; Curtis, Jeffrey L.; Martinez, Fernando J.; Pasquale, Cara B.; Merrill, Debora D.; Metzdorf, Norbert; Petruzzelli, Stefano; Tal-Singer, Ruth; Compton, Christopher; Rennard, Stephen I.; and Martin, Ubaldo J., "Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease" (2020). Journal Articles: Pulmonary & Critical Care Med. 27.
https://digitalcommons.unmc.edu/com_pulm_articles/27